By Christina England While reading the results of a vaccination trial on premature babies funded by GlaxoSmithKline, I noticed something was not quite right. The trial, whilst sickening in itself, was testing out the rotavirus vaccine on a group of 988 premature babies ranging between 27 weeks and 36 weeks. The paper reporting the trial […]